<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>myMeso | Raising mesothelioma awareness - Latest Comments</title><link xmlns="http://www.w3.org/2005/Atom" rel="http://api.friendfeed.com/2008/03#sup" href="http://disqus.com/sup/all.sup#forumcomments-c55c6eea" type="application/json"/><link>http://mesothelioma.disqus.com/</link><description></description><language>en</language><lastBuildDate>Sun, 01 Jun 2008 04:10:03 -0000</lastBuildDate><item><title>Re: Onconase fails in primary late-stage trial</title><link>http://www.mymeso.org/2008/05/30/onconase-fails-in-primary-late-stage-trial/#comment-566521</link><description>late-stage trial of the drug showed that Onconase did not achieve significantly higher survival rates among patients with unresectable malignant mesothelioma when given in combination with doxorubicin, another cancer chemotherapy drug.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">mesotheliomahq</dc:creator><pubDate>Sun, 01 Jun 2008 04:10:03 -0000</pubDate></item></channel></rss>